PFGIA
CYTK icon

Patriot Financial Group Insurance Agency’s Cytokinetics CYTK Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$9K – 2080
2021
Q4 		$9K Sell
200
-750
-79% -$28.9K ﹤0.01% 1517
2021
Q3 		$34K Hold
950
– – 0.01% 1008
2021
Q2 		$19K Hold
950
– – ﹤0.01% 1198
2021
Q1 		$22K Hold
950
– – 0.01% 1046
2020
Q4 		$20K Buy
+950
New +$17.4K 0.01% 961

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Patriot Financial Group Insurance Agency's CYTK Position: Q1 2022 in Review

Patriot Financial Group Insurance Agency sold out of Cytokinetics (CYTK) in Q1 2022, closing a stake of 200 shares — an estimated $9K sold.

Patriot Financial Group Insurance Agency first reported a position in CYTK in Q4 2020 and held it in 5 quarters. The position peaked at $34K in Q3 2021. 240 funds tracked by Wall St. Rank hold CYTK as of Q1 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Cytokinetics position as of Q1 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 200 Cytokinetics shares in Q1 2022, an estimated $9K.
  • Patriot Financial Group Insurance Agency first reported a position in Cytokinetics in Q4 2020 and held it in 5 quarters.
  • Patriot Financial Group Insurance Agency's Cytokinetics position peaked at $34K in Q3 2021.
  • 240 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2022, filed 11 May 2022.